Epidemiology and Management of Unconjugated Hyperbilirubinemia

Mohammed Salah Hussein

Department of Gastroenterology and Endoscopy, Dr. Samir Abbas Hospital, Jeddah, Saudi Arabia and Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

Walid Hajaj AlOrainy

King Saud University, Saudi Arabia.

Abdullah Mohammed Daghriri

Eradah (Al Amal) Mental Health Complex, Jeddah, Saudi Arabia.

Khalid Mohammed Alotaibi

Dankook University College of Medicine, South Korea.

Afnan Hamdan Owayn Alanazi

Northern Border University, Saudi Arabia.

Husam Abdulaziz Alkhathlan

King Saud University, Saudi Arabia.

Raghad Abdullah Alsaaedi

King Abdulaziz University, Saudi Arabia.

Najd Adnan Alamoudi

Alfaisal University, Saudi Arabia.

Faisal Abdulmohsen Bin Talib

King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia.

Muzaynah Abdullah Al Ali

Security Forces Health Center in Jazan, Saudi Arabia.

Mohammed Abdullatif Alowaidi

King Saud Bin Abdulaziz University for Health Sciences, Saudi Arabia.

Naif salem H Alshammari

Mental Health Hospital in Hafr Albatin, Saudi Arabia.

Laila Mohammed Mujarribi

Samtah General Hospital, Jazan, Saudi Arabia.

Rayan Saad Ahmed Almalki

King Salman Hospital / Riyadh, Saudi Arabia.

Afnan Abdullah Ahmed Oraijah

King Faisal Medical Complex, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Unconjugated hyperbilirubinemia is characterised by increased serum or plasma bilirubin (unconjugated) levels that exceed the laboratory's reference range. Unconjugated hyperbilirubinemia, is the most common cause of jaundice in newborns. Unconjugated hyperbilirubinemia is caused by bilirubin metabolism dysregulation, which includes increased synthesis, reduced hepatic absorption, and decreased bilirubin conjugation. Gilbert syndrome (type 1 and 2), Crigler-Najjar syndromes (type 1 and 2), and hereditary illnesses producing hemolytic anaemia are all examples of inherited conditions that can cause unconjugated hyperbilirubinemia. Crigler-Najjar syndrome is a sporadic condition, Gilbert syndrome is more common yet less dangerous symptom. Using phototherapy and plasmapheresis, the major goal of treatment is to lower the amount of unconjugated bilirubin. Intensive phototherapy is the basis of management of Crigler-Najjar syndrome type 1. Combined with plasmapheresis and in some cases liver transplantation may be required.

Keywords: Unconjugated, hyperbilirubinemia, epidemiology, crigler-najjar syndromes


How to Cite

Hussein, Mohammed Salah, Walid Hajaj AlOrainy, Abdullah Mohammed Daghriri, Khalid Mohammed Alotaibi, Afnan Hamdan Owayn Alanazi, Husam Abdulaziz Alkhathlan, Raghad Abdullah Alsaaedi, et al. 2021. “Epidemiology and Management of Unconjugated Hyperbilirubinemia”. Journal of Pharmaceutical Research International 33 (60B):1337-45. https://doi.org/10.9734/jpri/2021/v33i60B34753.

Downloads

Download data is not yet available.